Fibrinogen replacement therapy for congenital fibrinogen deficiency
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
Hypercoagulability in cirrhosis: causes and consequences 1
Differential propensity for major hemorrhagic events in patients with different types of arterial disease
Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study
Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission
Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease
Heparin-associated thrombocytopenia in 24 401 patients with venous thromboembolism: findings from the RIETE Registry 1
Novel analysis of clinically relevant diagnostic errors in point-of-care devices
Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines
Body weight and fat mass index as strong predictors of factor VIII in vivo recovery in adults with hemophilia A
From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism?
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation
Controlling cancer growth from within the blood coagulation mechanism
Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study
Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation
Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein
Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments
Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children
Towards a recommendation for the standardization of the measurement of platelet-dependent thrombin generation 1
Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model
Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation
Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants
CD11b+ leukocyte microparticles are associated with high-risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromes